Company Filing History:
Years Active: 2009
Title: The Innovative Contributions of Li Peng in Medical Imaging and Therapy
Introduction
Li Peng, an innovative inventor based in Davis, California, has made significant strides in the field of medical technology. With a focus on peptide-based therapeutics, he has developed a unique approach to treating various health conditions. His work emphasizes the importance of high binding affinity, specificity, and stability in therapeutic applications.
Latest Patents
Li Peng holds a patent titled "Alpha-4 beta-1 integrin ligands for imaging and therapy." This groundbreaking invention introduces integrin ligands that comprise peptides with varying lengths, including unnatural and D-amino acids. The ligands are designed for multiple applications, such as treating cancer, inflammatory diseases, and autoimmune diseases. Additionally, they offer methods for imaging tumors, organs, or tissues within a subject, showcasing their dual functionality in both therapy and diagnostic imaging.
Career Highlights
Li Peng's career has been marked by his commitment to advancing medical technologies. Working at the University of California, he has contributed to various research endeavors aimed at improving patient outcomes through innovative therapies. His patent reflects not only his technical expertise but also his passion for addressing critical health issues through scientific discovery.
Collaborations
Throughout his career, Li has collaborated with esteemed colleagues, including Kit S. Lam and Ruiwu Liu. These partnerships have fostered an environment of shared knowledge and collective innovation, paving the way for new advancements in medical research and application.
Conclusion
Li Peng stands out as a noteworthy inventor whose work has the potential to transform the landscape of medical imaging and therapeutic strategies. His groundbreaking patent reflects a significant contribution to the health sciences, highlighting the importance of continued innovation in addressing disease and improving patient care. The collaborative efforts at the University of California further amplify the impact of his work, as it continues to inspire future advancements in the field.